Sản phẩm tự nhiên cho hóa trị ung thư

10.1073/pnas.77.7.3957

10.1139/W05-122

Antoine N., 1994, AGM‐1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle, Cancer Res, 54, 2073

10.1021/jm00241a013

10.1016/j.bcp.2008.12.013

10.1021/np990176i

10.1128/jb.172.9.4816-4826.1990

10.1021/bi702019z

Berdy J., 1995, Are actinomycetes exhausted as a source of secondary metabolites?, Biotechnologia, 7, 13

10.1016/j.chembiol.2007.07.008

Blokhin A.V., 1995, Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure‐activity studies with analogues, Mol Pharmacol, 48, 523

Bringi V. andKadkade P.G.(1993)Enhanced production of taxol and taxanes by cell cultures ofTaxusspecies. Patent WO93/17121.

10.1073/pnas.2436348100

10.1073/pnas.0806582105

10.1023/A:1005658405449

10.1073/pnas.95.16.9642

Chung K.‐T., 2009, H. Boyd Woodruff (b. 1917): antibiotics hunter and distinguished soil microbiologist, SIM News, 59, 178

10.1021/ja00105a084

10.1517/13543784.9.12.2783

10.1016/j.jep.2005.05.011

10.1021/np9604893

10.1002/bit.20694

10.1517/13543784.16.11.1753

10.4103/0253-7613.41038

Duan L.‐L., 2008, Screening the high‐yield paclitaxel producing strain Alternaria alternate var monosporus, Chin J Antibiot, 33, 650

Duflos A. Fahy J. Thillaye du Boullay V. Barret J.‐M. andHill B.(2000)Vinca alkaloid antimitotic halogenated derivatives. US Patent 6127377.

10.1016/j.ymeth.2007.03.001

10.1016/S0022-5347(02)80301-9

10.7164/antibiotics.32.852

10.1007/978-1-4899-2391-2_12

10.7164/antibiotics.49.560

10.7164/antibiotics.53.1373

10.1200/JCO.2004.12.001

10.1016/S1074-5521(97)90198-8

Gross H., 2009, Genomic mining – a concept for the discovery of new bioactive natural products, Curr Opin Drug Discov Devel, 12, 207

10.1038/nm0202-128

10.1016/j.cell.2009.06.034

10.1016/j.drudis.2008.07.004

10.1002/(SICI)1521-3773(19990301)38:5<643::AID-ANIE643>3.0.CO;2-G

10.1021/jf901619w

10.1126/science.275.5296.38

Horwitz S.B., 1994, Taxol (paclitaxel): mechanisms of action, Ann Oncol, 5, S3

10.1128/AAC.39.7.1616

10.1038/348555a0

10.1007/s10482-004-6540-1

10.1016/S0378-1119(00)00149-9

10.7164/antibiotics.49.355

10.1007/s00253-003-1381-9

Kowalski R.J., 1997, The microtubule‐stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel‐resistant cells, Mol Pharmacol, 52, 4613, 10.1124/mol.52.4.613

10.1021/ja001017k

10.1021/jp0773536

10.1263/jbb.106.103

10.7164/antibiotics.44.934

10.7164/antibiotics.54.1

10.1248/yakushi.128.1681

10.1099/13500872-142-8-2223

10.1007/s00253-009-1856-4

10.1016/j.phytochem.2004.09.001

10.1007/BFb0102064

10.1021/jm048995

10.1038/nbt0198-69

10.1016/0163-7258(84)90025-1

10.1007/BF02862929

10.1016/j.bcp.2009.06.016

10.1016/j.chembiol.2008.01.006

Newman D.J., 2008, Microbial prescreens for anticancer activity, SIM News, 58, 132

10.1021/np030096l

10.1128/jb.177.10.2942-2945.1995

10.1016/j.phrs.2009.01.017

10.1021/np800606e

10.1021/ja907852c

10.1073/pnas.0405976101

Pray L., 2002, Strange bedfellows in transplant drug therapy, Scientist, 16, 36

10.1016/S0167-7799(02)02080-2

10.1021/cen-v076n025.p029

Rayl A.J.S., 1999, Oceans: medicine chests of the future?, Scientist, 13, 1

10.1038/nrd2382

10.1016/S1074-5521(96)90114-3

10.1146/annurev.micro.50.1.467

10.1016/S0167-7799(98)01198-6

10.1016/j.cellsig.2009.03.009

Sasaki A., 1998, Angiogenesis inhibitor TNP‐470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption, Cancer Res, 58, 462

10.1073/pnas.94.12.6099

10.1126/science.8097061

10.1080/07388550290789531

Strobel G.A., 1998, Endophytic microbes embody pharmaceutical potential, ASM News, 64, 263

10.1007/BF01575879

Strohl W.R., 1998, Biochemistry, molecular biology and protein‐protein interactions in daunorubicin/doxorubicin biosynthesis, Dev Ind Microbiol – BMP '97, 97, 15

Tanaka T., 1995, Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP‐470, Cancer Res, 55, 836

10.1126/science.287.5453.640

10.1039/B918106G

Thayer A., 2010, More than a supplier, Chem Eng News, 88, 25

10.1016/S1074-5521(99)80129-X

Umezawa H., 1972, Enzyme Inhibitors of Microbial Origin

10.1146/annurev.mi.36.100182.000451

10.1038/384011a0

10.1211/0022357001773931

10.7164/antibiotics.28.721

10.1016/0378-8741(95)01367-9

10.1111/j.1574-6968.2000.tb09432.x

10.1038/nchembio.2007.7

10.1103/PhysRevLett.83.1235

Yanase T., 1993, Inhibitory effect of angiogenesis inhibitor TNP‐470 on tumor growth and metastasis of human cell lines in vitro and in vivo, Cancer Res, 53, 2566

10.1099/13500872-142-8-1965

10.1038/nbt0996-1129

10.1038/nbt784

10.1002/cbic.200800389

Zhen Y.‐S., 2009, Antitumor antibiotic pingyangmycin: research and clinical use for 40 years, Chin J Antibiot, 34, 577